Image Image Image Image Image Image Image Image Image Image
Идти наверх

Идти наверх


· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

DMAE atrofica

· 19/03/2014

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD


· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD


· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  


· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

color nvc

· 16/01/2015

A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.

RD edema macular

· 21/12/2014

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.


· 23/12/2014

Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.

Injeccions (2)

· 23/12/2014

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.


· 20/11/2014

Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach.


· 02/07/2014

Clinical Trial M-13-027: Evaluation of Clinical Outcomes Following Treatment with Systane® Balance in Dry Eye Subjects with Lipid Deficiency


· 02/07/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma

Traccio macular

· 02/07/2014

JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion


· 19/03/2014

TREND: A phase IIIb, randomized, a 12-month, Visual Acuity assessor-masked, interventional study assessing the efficacy and safety of the Treat and Extend vs monthly regimens of 0.5 mg ranibizumab in patients with newly diagnosed nAMD


· 19/03/2014

MACBETH. Phase IV Study to evaluate the efficacy of aflibercept in subjects with neovascular Age-related Macular Degeneration (wAMD), without optimal response to repeated monthly intravitreal injections of Anti Vascular Endothelial Growth Factor (Anti VEGF-A) Therapy

Last modified: 29 November, 2021 - 13:07